Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my priority is to protect the patients, the company’s long-term viability, and my own ethical integrity. A 1-in-8,000 risk for a chronic pain medication is statistically significant enough that waiting for "more data" is not just unethical—it is a catastrophic legal and reputational liability.Read the full answer
48-Hour Action Plan: Liver Failure Signal in Flagship Drug Guiding Principle First The side effect is real, the drug is in 4 million patients, and roughly 500 patients per year may develop liver failure (4M ÷ 8,000). Every day of delay is measured in preventable liver transplants and deaths.Read the full answer